Orlando Alessandro, Levy A Stewart, Rubin Benjamin A, Tanner Allen, Carrick Matthew M, Lieser Mark, Hamilton David, Mains Charles W, Bar-Or David
1Trauma Research Department and.
4Trauma Research Department, St. Anthony Hospital, Lakewood, Colorado.
J Neurosurg. 2018 Jun 15;130(5):1626-1633. doi: 10.3171/2018.1.JNS171906. Print 2019 May 1.
A paucity of studies have examined neurosurgical interventions in the mild traumatic brain injury (mTBI) population with intracranial hemorrhage (ICH). Furthermore, it is not understood how the dimensions of an ICH relate to the risk of a neurosurgical intervention. These limitations contribute to a lack of treatment guidelines. Isolated subdural hematomas (iSDHs) are the most prevalent ICH in mTBI, carry the highest neurosurgical intervention rate, and account for an overwhelming majority of all neurosurgical interventions. Decision criteria in this population could benefit from understanding the risk of requiring neurosurgical intervention. The aim of this study was to quantify the risk of neurosurgical intervention based on the dimensions of an iSDH in the setting of mTBI.
This was a 3.5-year, retrospective observational cohort study at a Level I trauma center. All adult (≥ 18 years) trauma patients with mTBI and iSDH were included in the study. Maximum length and thickness (in mm) of acute SDHs, the presence of acute-on-chronic (AOC) SDH, mass effect, and other hemorrhage-related variables were double-data entered; discrepant results were adjudicated after a maximum of 4 reviews. Patients with coagulopathy, skull fractures, no acute hemorrhage, a non-SDH ICH, or who did not undergo imaging on admission were excluded. Tentorial SDHs were not measured. The primary outcome was neurosurgical intervention (craniotomy, burr holes, intracranial pressure monitor placement, shunt, ventriculostomy, or SDH evacuation). Multivariate stepwise logistic regression was used to identify significant covariates, to assess interactions, and to create the scoring system.
There were a total of 176 patients included in our study: 28 patients did and 148 did not receive a neurosurgical intervention. There were no significant differences between neurosurgical intervention groups in 11 demographic and 22 comorbid variables. Patients with neurosurgical intervention had significantly longer and thicker SDHs than nonsurgical controls. Logistic regression identified thickness and AOC hemorrhage as being the most important variables in predicting neurosurgical intervention; SDH length was not. Risk of neurosurgical intervention was calculated based on the SDH thickness and presence of an AOC hemorrhage from a multivariable logistic regression model (area under the receiver operating characteristic curve 0.94, 95% CI 0.90-0.97; p < 0.001). With a decision point of 2.35% risk, we predicted neurosurgical intervention with 100% sensitivity, 100% negative predictive value, and 53% specificity.
This is the first study to quantify the risk of neurosurgical intervention based on hemorrhage characteristics in patients with mTBI and iSDH. Once validated in a second population, these data can be used to inform the necessity of interhospital transfers and neurosurgical consultations.
针对患有颅内出血(ICH)的轻度创伤性脑损伤(mTBI)人群,进行神经外科干预的研究较少。此外,尚不清楚ICH的大小如何与神经外科干预的风险相关。这些局限性导致缺乏治疗指南。孤立性硬膜下血肿(iSDH)是mTBI中最常见的ICH类型,神经外科干预率最高,并且在所有神经外科干预中占绝大多数。了解该人群中需要进行神经外科干预的风险,有助于制定决策标准。本研究的目的是在mTBI背景下,根据iSDH的大小量化神经外科干预的风险。
这是一项在一级创伤中心进行的为期3.5年的回顾性观察队列研究。所有成年(≥18岁)患有mTBI和iSDH的创伤患者均纳入本研究。急性硬膜下血肿的最大长度和厚度(以毫米为单位)、急性合并慢性(AOC)硬膜下血肿的存在、占位效应以及其他与出血相关的变量进行了双数据录入;最多经过4次复查后,对不一致的结果进行裁决。排除患有凝血病、颅骨骨折、无急性出血、非硬膜下血肿性ICH或入院时未进行影像学检查的患者。未测量天幕硬膜下血肿。主要结局是神经外科干预(开颅手术、钻孔、颅内压监测器置入、分流术、脑室造瘘术或硬膜下血肿清除术)。采用多变量逐步逻辑回归来识别显著的协变量、评估相互作用并创建评分系统。
本研究共纳入176例患者:28例接受了神经外科干预,148例未接受。神经外科干预组与非手术对照组在11个人口统计学变量和22个合并症变量方面无显著差异。接受神经外科干预的患者的硬膜下血肿长度更长、厚度更厚,显著高于非手术对照组。逻辑回归确定厚度和AOC出血是预测神经外科干预的最重要变量;硬膜下血肿长度不是。根据多变量逻辑回归模型的硬膜下血肿厚度和AOC出血情况计算神经外科干预的风险(受试者工作特征曲线下面积为0.94,95%CI为0.90 - 0.97;p < 0.001)。以2.35%的风险决策点,我们预测神经外科干预的敏感性为100%,阴性预测值为100%,特异性为53%。
这是第一项基于mTBI和iSDH患者出血特征量化神经外科干预风险的研究。一旦在另一人群中得到验证,这些数据可用于指导院际转运和神经外科会诊的必要性。